When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYCC - Cyclacel Pharmaceuticals GAAP EPS of -$0.42 beats by $0.27
Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals press release (NASDAQ:CYCC): Q1 GAAP EPS of -$0.42 beats by $0.27. As of March 31, 2022, cash and cash equivalents totaled $29.6 million, compared to $36.6 million as of December 31, 2021. The Company estimates that its available cash will fund currently planned programs through June 2023.